Generic Pharmacuetical Patent and FDA Law, 2024-2025 ed.
Publisher:
Thomson WestAuthor(s):
PROVIEW PLUS PRINT GENERIC PHARMACUETICAL PATENTITLEMENT AND FDA LAW SET
Format
Book & eBook
Purchase option
Monthly subscription - 2 year (24-month term)
Quantity
1
Total
/month
Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration (FDA) approval of generic drugs and the interaction of patents and FDA law. A practitioner’s guide, it walks the reader through the stages of drug approval, identifying the
ProView is the way to read Thomson Reuters eBooks and eLooseleafs, published primarily for legal, accounting, human resources, and tax professions. The Thomson Reuters ProView web-based application is accessed via your browser. With the new ProView web-app, offline capability is now available from your browser. The web application has a responsive design and is compatible with desktop, laptop, and mobile devices.
All monthly subscriptions are subject to a continuous subscription agreement meaning your subscription will automatically renew in future years unless you tell us otherwise.
Each Automatic Renewal Term will be 1 month in length (“Automatic Renewal Term”) and we will notify you of any changes - including your new price - at least 10 days before each Automatic Renewal Term begins. Either of us may cancel in writing at least 30 days before an Automatic Renewal Term starts.
All updates are included in your monthly subscription and will be delivered automatically as soon as they become available.
Read our Terms and Conditions.
.png){kind=logo}
